Skip to main content
Log in

Protection Against Adriamycin-Induced Cardiomyopathy by Carnosine in Rats: Role of Endogenous Antioxidants

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the effects of carnosine, a biological antioxidant, on the acute cardiac damage induced by a single dose of adriamycin in rats. The experimental design consisted of four groups: Control (saline, i.p.); carnosine (CAR; 10 mg/kg/day, i.p.); adriamycin (ADR; 16 mg/kg on the 14th day, i.p.); carnosine with adriamycin. Carnosine was given 2 weeks before and following adriamycin treatment. Blood samples were collected for analysis of plasma creatine kinase (CK) and plasma antioxidant enzymes, glutathione peroxidase (GSH-Px), Cu, Zn-superoxide dismutase (SOD), and catalase (CAT). The rats were then sacrificed, and the hearts were autopsied for hemodynamic study, ECG, and histopathological examination. Results showed that adriamycin produced evident cardiac damage revealed by hemodynamic change, histological alterations, decreased plasma antioxidant enzymes activities, and increased lipid peroxidation to the control value. Carnosine treatment led to significant attenuation of adriamycin-induced cardiomyopathy revealed by normalization of the LVDP, ST interval, CK, SOD, GSH-Px, CAT, and lipid peroxidation. An increase in oxidative stress and inactivation of SOD, GSH-Px, CAT by a single dose of adriamycin were prevented when carnosine was given 2 weeks before and on the same day adriamycin treatment was administered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Young RC, Ozols RF, Myers CE (1981) The anthracycline antineoplastic drugs. N Engl J Med 305:139–153

    Article  PubMed  CAS  Google Scholar 

  2. Chularojmontri L, Wattanapitayakul SK, Herunsalee A et al (2005) Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity. Biol Pharm Bull 28:1165–1171

    Article  PubMed  CAS  Google Scholar 

  3. Zhou GY, Zhao BL, Hou JW, Ma GE, Xin WJ (1999) Protective effects of sodium tanshinone IIA sulphonate against adriamycin-induced lipid peroxidation in mice hearts in vivo and in vitro. Pharmacol Res 40:487–491

    Article  PubMed  CAS  Google Scholar 

  4. Iliskovic N, Singal PK (1997) Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol 150:727–734

    PubMed  CAS  Google Scholar 

  5. Bharadwaj LA, Davies GF, Xavier IJ, Ovsenek N (2002) l-carnosine and verapamil inhibit hypoxia-induced expression of hypoxia inducible factor (HIF-1 alpha) in H9c2 cardiomyoblasts. Pharmacol Res 45:175–181

    Article  PubMed  CAS  Google Scholar 

  6. Kang JH (2007) Protective effects of carnosine and N-acetylcarnosine on salsolinol-mediated Cu, Zn-superoxide dismutase inactivation. Bull Korean Chem Soc 28:1881–1884

    Article  CAS  Google Scholar 

  7. Kang JH, Kim KS, Choi SY et al (2002) Protective effects of carnosine, homocarnosine and anserine against peroxyl radical-mediated Cu, Zn-superoxide dismutase modification. Biochim Biophys Acta 1570:89–96

    PubMed  CAS  Google Scholar 

  8. Fitzpatrick D, Amend JF, Squibb RL, Fisher H (1980) Effects of chronic and acute infections on tissue levels of carnosine, anserine and free histidine in rats and chickens. Proc Soc Exp Biol Med 165:404–408

    PubMed  CAS  Google Scholar 

  9. Fisher DE, Amend JF, Strumeyer DH, Fisher H (1978) A role for carnosine and anserine in histamine metabolism of the traumatized rat. Proc Soc Exp Biol Med 158:402–405

    PubMed  CAS  Google Scholar 

  10. Parrillo JE, Parker MM, Natanson C et al (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227–242

    PubMed  CAS  Google Scholar 

  11. Zaloga GP, Roberts PR, Black KW et al (1997) Carnosine is a novel peptide modulator of intracellular calcium and contractility in cardiac cells. Am J Physiol 272:H462–H468

    PubMed  CAS  Google Scholar 

  12. Lee JW, Miyawaki H, Bobst EV et al (1999) Improved functional recovery of ischemic rat hearts due to singlet oxygen scavengers histidine and carnosine. J Mol Cell Cardiol 31:113–121

    Article  PubMed  CAS  Google Scholar 

  13. Uchida K, Kawakishi S (1994) Identification of oxidized histidine generated at the active site of Cu, Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. J Biol Chem 269:2405–2410

    PubMed  CAS  Google Scholar 

  14. Choi SY, Kwon HY, Kwon OB, Kang JH (1999) Hydrogen peroxide-mediated Cu, Zn-superoxide dismutase fragmentation: protection by carnosine, homocarnosine and anserine. Biochim Biophys Acta 1472:651–657

    PubMed  CAS  Google Scholar 

  15. Jewett SL, Rocklin AM, Ghanevati M, Abel JM, Marach JA (1999) A new look at a time-worn system: oxidation of CuZn-SOD by H2O2. Free Radic Biol Med 26:905–918

    Article  PubMed  CAS  Google Scholar 

  16. Begum G, Cunliffe A, Leveritt M (2005) Physiological role of carnosine in contracting muscle. Int J Sport Nutr Exerc Metab 15:493–514

    PubMed  CAS  Google Scholar 

  17. Hipkiss AR, Preston JE, Himsworth DT et al (1998) Pluripotent protective effects of carnosine, a naturally occurring dipeptide. Ann NY Acad Sci 854:37–53

    Article  PubMed  CAS  Google Scholar 

  18. Dimitrov NV, Hay MB, Siew S et al (1987) Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits. Am J Pathol 126:376–383

    PubMed  CAS  Google Scholar 

  19. Baykara B, Tekmen I, Pekcetin C et al (2009) The protective effects of carnosine and melatonin in ischemia-reperfusion injury in the rat liver. Acta Histochem 111:42–51

    Article  PubMed  CAS  Google Scholar 

  20. Lee YT, Hsu CC, Lin MH, Liu KS, Yin MC (2005) Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol 513:145–150

    Article  PubMed  CAS  Google Scholar 

  21. Mikami K, Otaka M, Watanabe D et al (2006) Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72. J Gastroenterol Hepatol 21:1669–1674

    Article  PubMed  CAS  Google Scholar 

  22. Saad SY, Najjar TA, Arafah MM (2006) Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats. Basic Clin Pharmacol Toxicol 99:412–417

    Article  PubMed  CAS  Google Scholar 

  23. Jain SK (1988) Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim Biophys Acta 937:205–210

    Article  PubMed  CAS  Google Scholar 

  24. Stocks J, Dormandy TL (1971) The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol 20:95–111

    Article  PubMed  CAS  Google Scholar 

  25. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169

    PubMed  CAS  Google Scholar 

  26. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500

    PubMed  CAS  Google Scholar 

  27. Beers RF Jr, Sizer IW (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133–140

    PubMed  CAS  Google Scholar 

  28. Li L, Takemura G, Li Y et al (2006) Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Circulation 113:535–543

    Article  PubMed  CAS  Google Scholar 

  29. Roberts PR, Zaloga GP (2000) Cardiovascular effects of carnosine. Biochemistry (Mosc) 65:856–861

    CAS  Google Scholar 

  30. Venkatesan N (1998) Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol 124:425–427

    Article  PubMed  CAS  Google Scholar 

  31. Fisher PW, Salloum F, Das A, Hyder H, Kukreja RC (2005) Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 111:1601–1610

    Article  PubMed  CAS  Google Scholar 

  32. le Marec H, Spinelli W, Rosen MR (1986) The effects of doxorubicin on ventricular tachycardia. Circulation 74:881–889

    Article  PubMed  Google Scholar 

  33. Jabr RI, Cole WC (1993) Alterations in electrical activity and membrane currents induced by intracellular oxygen-derived free radical stress in guinea pig ventricular myocytes. Circ Res 72:1229–1244

    PubMed  CAS  Google Scholar 

  34. Pacher P, Liaudet L, Bai P et al (2002) Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther 300:862–867

    Article  PubMed  CAS  Google Scholar 

  35. Saad SY, Najjar TA, Al-Rikabi AC (2001) The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 43:211–218

    Article  PubMed  CAS  Google Scholar 

  36. Timioglu O, Kutsal S, Ozkur M et al (1999) The effect of EGb 761 on the doxorubicin cardiomyopathy. Res Commun Mol Pathol Pharmacol 106:181–192

    PubMed  CAS  Google Scholar 

  37. Herman EH, Zhang J, Rifai N et al (2001) The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity. Cancer Chemother Pharmacol 48:297–304

    Article  PubMed  CAS  Google Scholar 

  38. Mostafa AM, Nagi MN, Al Rikabi AC, Al-Shabanah OA, El-Kashef HA (1999) Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats. Res Commun Mol Pathol Pharmacol 106:193–202

    PubMed  CAS  Google Scholar 

  39. Halliwell B (1991) Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91:14S–22S

    Article  PubMed  CAS  Google Scholar 

  40. Daosukho C, Chen Y, Noel T et al (2007) Phenylbutyrate, a histone deacetylase inhibitor, protects against adriamycin-induced cardiac injury. Free Radic Biol Med 42:1818–1825

    Article  PubMed  CAS  Google Scholar 

  41. Mukherjee S, Banerjee SK, Maulik M et al (2003) Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression. BMC Pharmacol 3:16

    Article  PubMed  Google Scholar 

  42. Li T, Danelisen I, Bello-Klein A, Singal PK (2000) Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc Res 46:523–530

    Article  PubMed  CAS  Google Scholar 

  43. Hartman PE, Hartman Z, Ault KT (1990) Scavenging of singlet molecular oxygen by imidazole compounds: high and sustained activities of carboxy terminal histidine dipeptides and exceptional activity of imidazole-4-acetic acid. Photochem Photobiol 51:59–66

    Article  PubMed  CAS  Google Scholar 

  44. Harman D (1991) The aging process: major risk factor for disease and death. Proc Natl Acad Sci USA 88:5360–5363

    Article  PubMed  CAS  Google Scholar 

  45. Sharonov BP, Govorova N, Lyzlova SN (1990) Carnosine as a potential scavenger of oxidants generated by stimulated neutrophils. Biochem Int 21:61–68

    PubMed  CAS  Google Scholar 

  46. Hartman PE (1986) Interception of toxic agents/mutagens/carcinogens: some of nature’s novel strategies. Basic Life Sci 39:169–179

    PubMed  CAS  Google Scholar 

  47. Fontana M, Pinnen F, Lucente G, Pecci L (2002) Prevention of peroxynitrite-dependent damage by carnosine and related sulphonamido pseudodipeptides. Cell Mol Life Sci 59:546–551

    Article  PubMed  CAS  Google Scholar 

  48. Nagasawa T, Yonekura T, Nishizawa N, Kitts DD (2001) In vitro and in vivo inhibition of muscle lipid and protein oxidation by carnosine. Mol Cell Biochem 225:29–34

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nurcan Dursun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dursun, N., Taşkın, E. & Öztürk, F. Protection Against Adriamycin-Induced Cardiomyopathy by Carnosine in Rats: Role of Endogenous Antioxidants. Biol Trace Elem Res 143, 412–424 (2011). https://doi.org/10.1007/s12011-010-8875-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-010-8875-y

Keywords

Navigation